JAK-STAT pathway, type I/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid
Autoimmune Bullous Diseases (AIBDs), characterized by the formation of blisters due to autoantibodies targeting structural proteins, pose significant therapeutic challenges. Current treatments, often involving glucocorticoids or traditional immunosuppressants, are limited by their non-specificity an...
Saved in:
| Main Authors: | Xiaoying Lin, Xiang Li, Zhifang Zhai, Mingwang Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1563286/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid
by: Na Zhang, et al.
Published: (2025-06-01) -
Bullous pemphigoid treated with baricitinib as steroid-sparing therapy for a patient with uncontrolled diabetes
by: Ji Won Heo, MD, et al.
Published: (2025-03-01) -
Correction: Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid
by: Na Zhang, et al.
Published: (2025-07-01) -
Bullous pemphigoid after Split Skin grafting in vitiligo patient
by: Siddharth Bhatt, et al.
Published: (2024-12-01) -
The relevance of HLA class II histocompatibility gens in predicting the risk of developing several bullous dermatoses
by: Marianna Drozhdina, et al.
Published: (2025-03-01)